Patent · US Active

Soluble C5aR antagonists

US10487098B2 · kind B2 · utility

5Cited by
3References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 19, 2019
Grant dateNov 26, 2019
Priority date—
Expiry dateMar 19, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/59
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.